Brown Spider Venom Phospholipase-D Activity upon Different Lipid Substrates

Nenhuma Miniatura disponível

Data

2023-02-01

Autores

Chaves-Moreira, Daniele
Gremski, Luiza Helena
de Moraes, Fábio Rogério [UNESP]
Vuitika, Larissa
Wille, Ana Carolina Martins
Hernández González, Jorge Enrique [UNESP]
Chaim, Olga Meiri
Senff-Ribeiro, Andrea
Arni, Raghuvir Krishnaswamy [UNESP]
Veiga, Silvio Sanches

Título da Revista

ISSN da Revista

Título de Volume

Editor

Resumo

Brown spider envenomation results in dermonecrosis, characterized by an intense inflammatory reaction. The principal toxins of brown spider venoms are phospholipase-D isoforms, which interact with different cellular membrane components, degrade phospholipids, and generate bioactive mediators leading to harmful effects. The Loxosceles intermedia phospholipase D, LiRecDT1, possesses a loop that modulates the accessibility to the active site and plays a crucial role in substrate. In vitro and in silico analyses were performed to determine aspects of this enzyme’s substrate preference. Sphingomyelin d18:1/6:0 was the preferred substrate of LiRecDT1 compared to other Sphingomyelins. Lysophosphatidylcholine 16:0/0:0 was preferred among other lysophosphatidylcholines, but much less than Sphingomyelin d18:1/6:0. In contrast, phosphatidylcholine d18:1/16:0 was not cleaved. Thus, the number of carbon atoms in the substrate plays a vital role in determining the optimal activity of this phospholipase-D. The presence of an amide group at C2 plays a key role in recognition and activity. In silico analyses indicated that a subsite containing the aromatic residues Y228 and W230 appears essential for choline recognition by cation-π interactions. These findings may help to explain why different cells, with different phospholipid fatty acid compositions exhibit distinct susceptibilities to brown spider venoms.

Descrição

Palavras-chave

brown spider, Loxosceles intermedia, phospholipase-D substrate, phospholipids, recombinant toxin, venom

Como citar

Toxins, v. 15, n. 2, 2023.